Teladoc Health Inc vs Valero Energy Corporation — how do they compare? Teladoc Health Inc trades at $5.77 (market cap $1.01B), while Valero Energy Corporation trades at $433.75 (market cap $127.78B). The key difference: Valero Energy Corporation is far larger — about 126.5× Teladoc Health Inc's market cap, and Valero Energy Corporation pays a 1.08% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Valero Energy Corporation for 56 Days on average.
| TDOC | VLO | |
|---|---|---|
Market Cap | $1.01B | $127.78B |
Volume | 4,668,477 | 2,570,225 |
Sector | Health | Energy |
52-Week High | $9.72 | $443.80 |
52-Week Low | $4.47 | $156.39 |
Typical Hold Time | 39 Days | 56 Days |
Enterprise Value | $1.27B | $131.26B |
Dividend Yield | — | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Teladoc Health (TDOC) trades at $5.77, up 3.78% today but remains near multi-year lows amid ongoing profitability challenges. The stock shows bearish technical signals with mixed earnings performance, having beaten estimates in two of the last three quarters but posting consistent net losses. Recent management changes include the appointment of a new CFO and legal officer as the company focuses on stabilizing its integrated care business while grappling with BetterHelp segment weakness.
While TDOC trades at discounted valuation multiples (P/S 0.4x, P/B 0.77x) and analysts maintain a $8.83 price target, the path to profitability remains uncertain given seven consecutive quarters of negative earnings. The primary investment thesis hinges on the company's ability to monetize its chronic care platform and achieve sustainable free cash flow generation, though investor sentiment remains cautious amid ongoing losses and competitive pressures in virtual healthcare.
Valero Energy (VLO) trades at $443.8, up 4.65% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though RSI levels indicate overbought conditions. Fundamentally, VLO has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $20.17 EPS. Revenue has declined from $176.4B in 2022 to $122.7B in 2025, but net income margin improved to 5.17% in 2026 projections. Analyst sentiment is predominantly positive with 54% buy ratings.
VLO's outlook is supported by refining margin strength and a solid balance sheet, but risks include potential diesel export bans and volatile energy markets. The consensus price target is $408.10, below the current price, suggesting limited near-term upside. Investors should weigh strong operational performance against macroeconomic and policy uncertainties in the energy sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →